Associazione Nazionale Medici Cardiologi Ospedalieri

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
A Late Primary Carnitine Deficiency Diagnosis in Adulthood during Arrhythmic Risk Reassessment in Hypertrophic Cardiomyopathy.
Anno:
2024
Background: Hypertrophic cardiomyopathy (HCM) is the most common inherited heart disease, typically caused by mutations in cardiac sarcomere protein genes. Inborn errors of metabolism are a rare cause of this condition, usually diagnosed in infancy due to severe heart failure and concurrent extracardiac manifestations. Clinical case: A 36-year-old female…
FIBROSIS QUANTIFICATION IN RISK STRATIFICATION OF HYPERTROPHIC CARDIOMYOPATHY
Anno:
2024
Late gadolinium enhancement (LGE) cardiac magnetic resonance (CMR) is the gold-standard modality to assess myocardial scar. The extent of myocardial fibrosis is proportional to the risk of adverse outcomes and LGE is ≥15% of LV mass is one of the criteria for prophylactic implantable cardioverted defibrillator. Currently, there are…
PERCUTANEOUS MITRAL PLICATION FOR WEANING BY VA-ECMO IN PATIENT WITH OBSTRUCTIVE SAM ASSOCIATED WITH PRECLINICAL PHENOTYPE OF HYPERTROPHIC CARDIOMYOPATHY AND STEMI COMPLICATED BY CARDIOGENIC SHOCK
Anno:
2024
A 53-year-old man with a history of hypertrophic obstructive cardiomyopathy with a preclinical phenotype, classified at low risk of sudden cardiac death (HCM-SCD risk score 2.98%), and cardiac arrest (OHCA) in the absence of a shockable rhythm. The patient underwent cardiopulmonary resuscitation for more than 30 minutes before the…
NOVEL INTEGRATED IMAGING PARAMETERS FOR RISK STRATIFICATION OF ATRIAL FIBRILLATION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
Anno:
2024
Abstract Background Atrial fibrillation (AF) impacts prognosis of hypertrophic cardiomyopathy (HCM) by promoting progressive heart failure (HF) and increasing risk of stroke. Over the past years, several indexes and methods to predict AF among HCM patients have been proposed. However, they are limited by a lack of accuracy. Aims…